Expression of EGFR,Grb2,p-mTOR and VEGF in human colorectal cancer tissues
Honggang Xiang(Second Military Medical University), Ziran Wei(Second Military Medical University), Jian Xu(University of California, Los Angeles), Zhiqian Hu(Tongji University), Qiang Wang(Jianghan University), Weijun Wang
Cited by 1
Related Papers
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
|Gastric Cancer|2014|615
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
|Molecular Carcinogenesis|2010|558
Drug resistance to targeted therapeutic strategies in non-small cell lung cancer
|Pharmacology & Therapeutics|2019|245
Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations
|Nature Genetics|2011|198
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer
|Cell Death and Disease|2018|150